You can also take potassium chloride through an extended-release tablet, extended-release capsule, injectable, oral solution, and powder for oral solution. Before you start or stop taking the ...

The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets. The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced ...

Company's current portfolio consists of 117 products authorised for distribution in the US marketplace and 61 ANDA pending approval with the USFDA.

Glenmark Laboratories recalled 114 batches of 750 mg Potassium Chloride Extended-Release Capsules in bottles of 100 (NDC No. 68462-357-01) and 500 (NDC No. 68462-357-05) capsules.

In draft guidance issued Friday, the FDA advised food manufacturers of its “intent to exercise enforcement discretion for the name ‘potassium chloride salt’ in the ingredient statement on ...

Shares of Strides Pharma Science rose 3 percent intraday Wednesday as company received United States Food & Drug Administration (USFDA) approval for Potassium Chloride extended release tablets ...

The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced by Merck Sharp & Dohm, a subsidiary of Kenilworth, N.J.-based Merck. The K Dur tablets reported ...

Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, used in treating low levels of potassium in blood.

Glenmark Laboratories recalled 114 batches of 750 mg Potassium Chloride Extended-Release Capsules in bottles of 100 (NDC No. 68462-357-01) and 500 (NDC No. 68462-357-05) capsules.

Citing IQVIA Health data, Granules said Potassium Chloride extended release tablets had US generic sales of approximately USD 204 million for the most recent 12 months ending in August 2020.